Anebulo Pharmaceuticals, Inc. (ANEB) Social Stream



Anebulo Pharmaceuticals, Inc. (ANEB): $2.10

0.08 (+3.96%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add ANEB to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#153 of 491

in industry

ANEBULO PHARMACEUTICALS INC (ANEB) Price Targets From Analysts

Use the tables below to see what analysts covering ANEBULO PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-06-18 1 $15.001 $15.001 $15.001 $2.4 525.04%
2022-05-27 2 $10 $10 $10 $2.4 316.67%
2022-11-14 2 $10 $6 $8 $2.4 233.33%
2023-05-15 2 $8 $6 $7 $2.4 191.67%
2023-09-18 3 $8 $6 $6.666 $2.4 177.75%
2023-09-25 4 $8 $6 $6.666 $2.4 177.75%
2023-10-02 4 $8 $6 $6.5 $2.4 170.83%

The Trend in the Analyst Price Target


ANEB's average price target has moved down $3.5 over the prior 16 months.

ANEB reports an average of 143.3% for its upside potential over the past 33 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-16 2 8 6 7.000 2.79 150.9%
2023-02-16 1 8 6 7.000 2.79 150.9%
2023-09-18 3 8 6 6.666 3.27 103.85%
2023-09-25 4 8 6 6.500 3.27 98.78%
2023-10-02 4 8 6 6.500 3.14 107.01%

ANEB Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 4 0 0 0 0 4

The Trend in the Broker Recommendations


ANEB's average broker recommendation rating improved by 0 over the prior 15 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ANEB as an investment opportunity.

  • ANEBULO PHARMACEUTICALS INC's number of analysts covering the stock is greater than 49.82% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, ANEBULO PHARMACEUTICALS INC's average analyst price target is higher than 86.47% of them.
  • In terms of how ANEBULO PHARMACEUTICALS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 883.45% of that group.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ANEBULO PHARMACEUTICALS INC's variance in analysts' estimates is lower than -25.15% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ANEBULO PHARMACEUTICALS INC are FLGC, ACXP, and HCWB.

What is the outlook for ANEB? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!